MIKE CORCORAN: Open Payments
NPI 1346210853 · LITTLETON, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,442 in 66 payments from 26 companies in 2025. Trend: 2023 $1,376 · 2024 $1,405 · 2025 $1,442
Food & beverage: $1,442
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $335 |
| PFIZER INC. | 10 | $207 |
| Novo Nordisk Inc | 6 | $142 |
| Lilly USA, LLC | 5 | $87 |
| Boston Scientific Corporation | 2 | $60 |
| Alexion Pharmaceuticals, Inc. | 2 | $52 |
| Amgen Inc. | 2 | $50 |
| GlaxoSmithKline, LLC. | 2 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $42 |
| Exact Sciences Corporation | 2 | $40 |
Products named: VRAYLAR, NURTEC ODT, Wegovy, QULIPTA, UBRELVY, STRENSIQ, KRYSTEXXA, SHINGRIX.
Industry payments across CO — which companies pay providers there.
